Table 3

Comparison of prevalence of myopic maculopathy reported in studies

StudyEthnicityExamined yearSample (n)Age (years)Definition of myopic maculopathyPrevalence OR, 95% CI, %
This current studyChinese20133044≥40Diffuse chorioretinal atrophy Patchy chorioretinal atrophy
Macular atrophy
Lacquer cracks
CNV
Fuchs’ spot
5.8 (4.8 to 6.8); age-adjusted
Hisayama Study13Southern Japanese20051892≥40Diffuse chorioretinal atrophy Patchy chorioretinal atrophy Lacquer cracks
Macular atrophy
1.7
Beijing Eye Study15Urban Chinese20014319≥40Staphyloma
Lacquer cracks
Fuchs’ spot
Chorioretinal atrophy
3.1
Shihpai Eye Study12Chinese20001058≥65Lacquer cracks
Deep choroidal atrophy
Geographic atrophy
CNV
3.0 (2.1 to 4.2)
Central India Eye and Medical Study16Rural Central
India
20064561>30Diffuse chorioretinal atrophy Patchy chorioretinal atrophy
Macular atrophy
Lacquer cracks
CNV
Fuchs’ spot
Posterior staphyloma
0.2 (0.1 to 0.4)
Blue Mountains Eye Study8Urban Australian1992–19943583≥49Staphyloma
Lacquer cracks
Fuchs’ spot
Chorioretinal atrophy
1.2
Yangxi Eye Study18Rural Southern Chinese20144469≥40Diffuse chorioretinal atrophy Patchy chorioretinal atrophy
Macular atrophy
Lacquer cracks
CNV
Fuchs’ spot
1.2 (1.1 to 1.2)
Handan Eye Study17Rural Northern Chinese2006–20076603≥30Staphyloma
Lacquer cracks
Fuchs’ spot
Chorioretinal atrophy
0.9 (0.7 to 1.1)
  • CNV, choroidal neovascularisation.